Penumbra (PEN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Penumbra (PEN) is Neutral.

The composite score behind that read is +0.10, weighing +0.11 of bullish evidence against -0.36 bearish.

Penumbra last closed at $319.40, +0.59% on the session.

Against the IVW growth benchmark the position is -0.21% over the forecast window.

The read is built from 15 underlying insights — 11 bullish and 4 bearish.

Agreement across those insights is 73%.

Penumbra has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Penumbra in the 8th percentile on valuation and the 63rd percentile on return on equity, where 100 is best.

Penumbra is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $12.51B.

StockMap tracks Penumbra as the 18th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Penumbra ranks 14th of 140 in the group, against a group median of -0.03.